EBV-positive tumours have a distinct molecular profile with high PD-L1 and PD-L2 expression, marked intra- or peritumoural immune cell infiltration, extreme DNA hypermethylation and recurrent PIK3CA mutations [37]. The gene discussed is CD274; the disease is neoplasm.